New IV stopper aims to cut catheter complications in hospitals
NCT ID NCT07519304
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a needle-free connector with anti-reflux technology, a special stopper that prevents blood from flowing back into IV catheters. The goal is to see if it reduces complications like blockages, infections, and pain compared to standard connectors. The trial will involve 62 hospitalized adults who need a long peripheral catheter for at least a week.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Needle-free connector with anti-reflux technology (Clave™ Neutron™)
- What this could lead to
- If it works, this could reduce catheter-related complications such as blockages, infections, and pain, improving patient comfort and safety during hospital stays.
- What could go wrong
- This is a small early-stage trial with only 62 participants, so results may not apply to all patients. The device may not significantly reduce complications compared to standard connectors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATHETERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new device suck out deadly lung clots?
- Simulated patients, real skills: a new training approach for future nurses
- Can a sedative help rebuilt tissue survive after cancer surgery?
- Your DNA could determine which heart drug works best
- Can a fully digital approach replace the wax bite in making night guards?
- 10,000 patients to reveal how safe midline catheters really are